The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Inhibition of MicroRNA-92a Protects Against Ischemia/Reperfusion Injury in a Large-Animal Model
Open accessAbstract
Background—: MicroRNAs (miRs) are small noncoding RNAs that posttranscriptionally control gene expression. Small-animal studies suggest that miRs might offer novel therapeutic targets in cardiovascular diseases such as cardioprotection of murine hearts after myocardial infarction via miR-92a inhibitors. Because the functional benefits of miR-92a inhibitors in larger preclinical models are not known, we assessed the therapeutic efficacy of miR-92a inhibition in a porcine model of ischemia and reperfusion. Methods and Results—: Pigs (n=5 per group) underwent percutaneous ischemia/reperfusion (60 min/72 h or 7 days, respectively). Locked nucleic acid–modified antisense miR-92a (LNA-92a) was applied either regionally (antegrade or retrograde) with a catheter or systemically (intravenously). LNA-92a significantly ( P <0.01) reduced miR-92a expression in the infarct zone regardless of the application venue. However, catheter-based delivery, but not intravenous infusion, of LNA-92a significantly ( P <0.05) reduced the infarct size compared with control LNA–treated pigs, which correlated with an improved ejection fraction and left ventricular end-diastolic pressure ( P <0.05). Histochemistry revealed that LNA-92a increased capillary density but decreased leukocyte influx and cardiac cell death. Complete loss of miR-92a in mice attenuated the infarct-related myocardial dysfunction to a larger extent than cardiomyocyte-specific miR-92a deletion. In vitro, LNA-92a protected against hypoxia/reoxygenation–induced cardiomyocyte cell death. Conclusions—: Regional LNA-92a delivery reduces miR-92a levels and infarct size and postischemic loss of function. LNA-92a exerts cell-protective, proangiogenic, and anti-inflammatory effects. miR-92a inhibition might be a novel therapeutic tool to preserve cardiac function after ischemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Self-citationLNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., Burchfield, J., Fox, H., Doebele, C., Ohtani, K., et al. (2009) · Science · doi:10.1126/science.1174381 · Cited by 1,215
Self-citationRegulation of the Inflammatory Response in Cardiac Repair
Frangogiannis, N. G. (2012) · Circulation Research · doi:10.1161/circresaha.111.243162 · Cited by 1,194
Pervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180
Inhibition of miR-15 Protects Against Cardiac Ischemic Injury
Hullinger, T. G., Montgomery, R. L., Seto, A. G., Dickinson, B. A., Semus, H. M., Lynch, J. M., Dalby, C. M., Robinson, K., Stack, C., Latimer, P. A., et al. (2012) · Circulation Research · doi:10.1161/circresaha.111.244442 · Cited by 501
Self-citationDoebele, C., Bonauer, A., Fischer, A., Scholz, A., Reiss, Y., Urbich, C., Hofmann, W.-K., Zeiher, A. M., & Dimmeler, S. (2010) · Blood · doi:10.1182/blood-2010-01-264812 · Cited by 362
Self-citationStress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice
Patrick, D. M., Montgomery, R. L., Qi, X., Obad, S., Kauppinen, S., Hill, J. A., van Rooij, E., & Olson, E. N. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43604 · Cited by 360
Self-citationmiR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes
Qian, L., Van Laake, L. W., Huang, Y., Liu, S., Wendland, M. F., & Srivastava, D. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101547 · Cited by 322
Pan, Z., Sun, X., Shan, H., Wang, N., Wang, J., Ren, J., Feng, S., Xie, L., Lu, C., Yuan, Y., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.094524 · Cited by 312
Discovering the first microRNA-targeted drug
Lindow, M., & Kauppinen, S. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201208082 · Cited by 302
Wang, X., Zhang, X., Ren, X.-P., Chen, J., Liu, H., Yang, J., Medvedovic, M., Hu, Z., & Fan, G.-C. (2010) · Circulation · doi:10.1161/circulationaha.110.964684 · Cited by 298
Statin treatment after onset of sepsis in a murine model improves survival.
Merx, M. W., Liehn, E. A., Graf, J., van de Sandt, A., Schaltenbrand, M., Schrader, J., Hanrath, P., & Weber, C. (2005) · Circulation · doi:10.1161/circulationaha.104.502195 · Cited by 287
Fang, Y., & Davies, P. F. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.244053 · Cited by 282
Flow-Dependent Regulation of Krüppel-Like Factor 2 Is Mediated by MicroRNA-92a
Wu, W., Xiao, H., Laguna-Fernandez, A., Villarreal, G., Wang, K.-C., Geary, G. G., Zhang, Y., Wang, W.-C., Huang, H.-D., Zhou, J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.005108 · Cited by 280
MicroRNA therapeutics in cardiovascular medicine
Thum, T. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100191 · Cited by 193
Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins
Boekstegers, P., von Degenfeld, G., Giehrl, W., Heinrich, D., Hullin, R., Kupatt, C., Steinbeck, G., Baretton, G. B., Middeler, G., Katus, H. A., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301079 · Cited by 164
Self-citationHinkel, R., El-Aouni, C., Olson, T., Horstkotte, J., Mayer, S., Müller;, S., Willhauck, M., Spitzweg, C., Gildehaus, F.-J., Münzing, W., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.758904 · Cited by 151
Self-citationA Locked Nucleic Acid Oligonucleotide Targeting MicroRNA 122 Is Well-Tolerated in Cynomolgus Monkeys
Hildebrandt-Eriksen, E. S., Aarup, V., Persson, R., Hansen, H., Munk, M. E., & Ørum, H. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2011.0332 · Cited by 108
Raake, P. W. J., Hinkel, R., Müller, S., Delker, S., Kreuzpointner, R., Kupatt, C., Katus, H. A., Kleinschmidt, J. A., Boekstegers, P., & Müller, O. J. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303035 · Cited by 93
Self-citationRegulation of Cardiac MicroRNAs by Bone Marrow Mononuclear Cell Therapy in Myocardial Infarction
Iekushi, K., Seeger, F. H., Aßmus, B., Zeiher, A. M., & Dimmeler, S. (2012) · Circulation · doi:10.1161/circulationaha.111.079699 · Cited by 83
Self-citationKupatt, C., Hinkel, R., Lamparter, M., von Brühl, M.-L., Pohl, T., Horstkotte, J., Beck, H., Müller, S., Delker, S., Gildehaus, F., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.524801 · Cited by 75
Self-citationKupatt, C., Hinkel, R., von Brühl, M.-L., Pohl, T., Horstkotte, J., Raake, P. W. J., El-Aouni, C., Thein, E., Dimmeler, S., Féron, O., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.047 · Cited by 43
Self-citation
Cited by
Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches
Beermann, J., Piccoli, M.-T., Viereck, J., & Thum, T. (2016) · Physiological Reviews · doi:10.1152/physrev.00041.2015 · Cited by 1,726
miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges
Zhou, S.-S., Jin, J.-P., Wang, J.-Q., Zhang, Z.-G., Freedman, J. H., Zheng, Y., & Cai, L. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2018.30 · Cited by 675
MicroRNA Regulation of Atherosclerosis
Feinberg, M. W., & Moore, K. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.306300 · Cited by 627
Development of microRNA therapeutics is coming of age
van Rooij, E., & Kauppinen, S. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201100899 · Cited by 625
Self-citationCardiovascular consequences of metabolic syndrome
Tune, J. D., Goodwill, A. G., Sassoon, D. J., & Mather, K. J. (2017) · Translational Research · doi:10.1016/j.trsl.2017.01.001 · Cited by 568
Metadata
- Authors
- Hinkel, R., Penzkofer, D., Zühlke, S., Fischer, A., Husada, W., Xu, Q.-F., Baloch, E., van Rooij, E., Zeiher, A. M., Kupatt, C., & Dimmeler, S.
- Venue
- Circulation
- Published
- 2013-09-03
- Volume
- 128
- Issue
- 10
- Pages
- 1066-1075
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2117903449
- Cited by
- 317
- References
- 24
- FWCI
- 21.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.